Navigation Links
Bayer and Onyx Announce Nexavar Data Presentations at the Joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress
Date:9/15/2009

WAYNE, N.J. and EMERYVILLE, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that approximately 30 studies evaluating the use of Nexavar((R)) (sorafenib) tablets across tumor types - as a single agent or in combination with other therapies - will be presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress, September 20 - 24 in Berlin.

"The presentations at the ECCO/ESMO conference will continue to build on our large body of data in unresectable liver cancer and advanced kidney cancer where Nexavar has a proven track record," said Dimitris Voliotis, Vice President, Global Clinical Development Oncology. "Additionally, Bayer and Onyx are enthusiastic about presenting Phase 2 studies evaluating the safety and efficacy of Nexavar in other tumor types, including breast and thyroid cancers."

Nexavar data highlights include:

Hepatocellular Carcinoma

  • Effect of Macroscopic Vascular Invasion (MVI), Extrahepatic Spread (EHS), and ECOG Performance Status (ECOG PS) on Outcome in Patients with Advanced Hepatocellular Carcinoma (HCC) Treated with Sorafenib: Analysis of Two Phase 3, Randomized Double-Blind Trials
    • Jean-Luc Raoul, M.D., Centre Eugene Marquis, Rennes, France
    • Abstract 6621, Poster 309, Wednesday, September 23, 2009, 2 p.m. - 5 p.m., Hall 14.1

  • Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC): Collective Results from the Phase III Sorafenib HCC Assessment Randomized
    '/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
2. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
3. Bayer HealthCare Cleared to Acquire Citracal(R)
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. Bayer Temporarily Suspends Global Trasylol(R) Marketing
8. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
9. Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials
10. Bayer Awards Making Science Make Sense Grant to Girl Scouts
11. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... New York, New York (PRWEB) May 25, 2015 ... and distributor of patented products, launches the Big Little ... ability to customize the perfect table that will suit ... reached a whopping revenue of $646 billion this past ... billion a year industry" says Scott J. Cooper, CEO ...
(Date:5/25/2015)... HomeCare is proud to announce that David Allerby, Co-Founder ... Iwamoto, Co-Founder & CMO, are Finalists for the Ernst ... Greater Los Angeles. The award is presented by EY ... and a personal commitment to their communities. , “Our ... of our organization,” said Co-Founder & CEO, David Allerby, ...
(Date:5/25/2015)... MA (PRWEB) May 25, 2015 A recent ... 2015 states 1,000 persons have died as a direct result ... 2014. This marks a 33% rise in overdose deaths attributed ... Charlie Baker, “This issue doesn’t care about geography. This issue ... This issue doesn’t care about class.” As the state of ...
(Date:5/25/2015)... May 25, 2015 Thousands of ... move forward in the federal multidistrict litigation now ... Texas. According to a Motion filed on May ... modify the Case Management Order pertaining to the ... things, the Motion seeks the adoption of a ...
(Date:5/25/2015)... CA (PRWEB) May 25, 2015 Join Fiona's ... a free two-hour instructional clinic. Irish National Player, Fiona ... and give them a taste of her coaching style. Fiona ... and Novato. Camps in Novato are at Lynwood Elmentary School ... , Novato High School - June 6th, 2015 - 1:00-3:00pm. ...
Breaking Medicine News(10 mins):Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 2Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 3Health News:24Hr HomeCare Co-Founders Named Finalists for EY Entrepreneur of the Year 2015 Awards 2Health News:Opioid Deaths Increase by 33 Percent Since 2012 in Mass. 2Health News:Federal DePuy Pinnacle Hip Lawsuits Move Forward, as Plaintiffs Seek to Modify Order Pertaining to Health Authorizations 2Health News:Federal DePuy Pinnacle Hip Lawsuits Move Forward, as Plaintiffs Seek to Modify Order Pertaining to Health Authorizations 3Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2
... ... Products LLC is proud to announce the unveiling of its brand ... prices directly to the American Consumer. TouchstoneSaunas.com offers premium quality ... home. Constructed from the highest quality materials to provide many ...
... ... and Earth Day Celebration Saturday, April 17. , ... Golden, CO (PRWEB) April 17, 2010 -- Panorama Orthopedics & Spine ... and Arbor Day April 17. As part of its companywide green initiative, launched last year, ...
... As a ... team of expert negotiators who will act as buying agents for their elite group of ... New York, NY ... The Leading Physicians of the World is even further empowering their members by representing their ...
... A major ... debate surrounding the provision of open educational resources (OER) by revealing the key factors surrounding ... ... Dr Ann Hemingway investigated the barriers and enablers of free online public health education as ...
... ... Success , ... MA (Vocus) April 16, 2010 -- Blue Cross Blue Shield of Massachusetts ... over 160 firefighters in seven cities/towns (Arlington, Framingham, Hingham, Hudson, Ludlow, Peabody and Rockland) ...
... (April 15, 2010) -- Nine-year-old Morgan LaRue is the first ... that will magnetically lengthen her leg, sparing her the possibility ... The implant and extension took place at Texas Children,s Cancer ... Children,s Cancer Center or the device, please see http://bit.ly/MorganLaRue ...
Cached Medicine News:Health News:Touchstone Saunas Goes Online to Provide Premium Quality Infrared Saunas 2Health News:Panorama Orthopedics and the City of Westminster Join Forces to Improve the Environment through Tree Giveaway 2Health News:Exclusive Medical Organization, The Leading Physicians of the World Negotiates Equipment Contracts on Their Members Behalf 2Health News:BU Study Contributes to Online Health Education Debate 2Health News:BU Study Contributes to Online Health Education Debate 3Health News:Firefighters Walk Over 60,000 Miles in Blue Cross Blue Shield of Massachusetts' Fitness Challenge 2Health News:Firefighters Walk Over 60,000 Miles in Blue Cross Blue Shield of Massachusetts' Fitness Challenge 3Health News:Firefighters Walk Over 60,000 Miles in Blue Cross Blue Shield of Massachusetts' Fitness Challenge 4Health News:Texas Children's Cancer Center first in Texas to magnetically lengthen 9-year-old's leg as she grows 2
(Date:5/22/2015)... InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), ... that its CGuard TM Embolic Prevention System reported positive ... Musialek , at the EuroPCR conference on May ... PARADIGM, an investigator-initiated P rospective evaluation of ... revascularization I n symptomatic and increased-risk asymptomatic carotid artery ...
(Date:5/22/2015)... Richmond Pharmacology is a ... a worldwide reputation for excellence in clinical trials. ... peer reviewed medical journals. Its officers are engaged ... discussions about rules for transparency and publication of ... , Clinical research is conducted worldwide, ...
(Date:5/21/2015)... CHICAGO , May 21, 2015 /PRNewswire-USNewswire/ ... lump along the side of his neck, ... and took a couple weeks off from ... didn,t go away.                               ... Rendino, 26, was referred to Michel ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... LAWRENCE, Mass., Nov. 9, 2010 NxStage Medical, ... manufacturer of innovative dialysis products, today announced that ... Brown, Chief Financial Officer, will participate in the ... Healthcare Summit Boston Harbor Hotel Boston, MATuesday, November ...
... ATLANTA, Nov. 9, 2010 The addition of ... associated with a rapid clinical response, improved function ... of adult rheumatoid arthritis (RA) patients reflecting those ... prior TNF-inhibitor use).  These positive clinical trial data ...
Cached Medicine Technology:NxStage Announces Fourth Quarter 2010 Investor Conference Schedule 2New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 2New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 3New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 4New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 5New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 6New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 7New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 8New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 9New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 10
Inquire...
Inquire...
Inquire...
... first time, the Integrated Cytometry Solution ... post-analytical solution coupled with complete LIS ... steps a sample undergoes - and ... one - it delivers a progressive ...
Medicine Products: